Results 1 to 10 of about 21,465 (244)

Expanding the Microbial Genomic Landscape and Biotechnological Applications of CRISPR-Cas Systems [PDF]

open access: yesBiology
The CRISPR-Cas systems, identified initially as adaptive immune mechanisms in bacteria and archaea against viral threats, have rapidly evolved into transformative tools in genetic engineering and biotechnology.
Swati Singh   +5 more
doaj   +2 more sources

A leader-repeat hairpin blocks extraneous CRISPR RNA production in diverse CRISPR-Cas13 systems [PDF]

open access: yesThe EMBO Journal
CRISPR RNAs (crRNAs) guide recognition and targeting of intracellular invaders as part of adaptive immunity by CRISPR-Cas systems. crRNAs are transcribed from CRISPR arrays of conserved repeats interlaced with invader-derived spacers.
Angela Migur   +8 more
doaj   +2 more sources

A Rapid Hairy Root-Based Platform for CRISPR/Cas Optimization and Guide RNA Validation in Lettuce [PDF]

open access: yesPlants
Cultivated lettuce (Lactuca sativa L.) is a major leafy crop and an emerging model for functional genomics within the Asteraceae family, supported by high-quality reference genomes and efficient transformation systems.
Alberico Di Pinto   +10 more
doaj   +2 more sources

How to Find the Right RNA-Sensing CRISPR-Cas System for an In Vitro Application

open access: yesBiosensors, 2022
CRISPR-Cas systems have a great and still largely untapped potential for in vitro applications, in particular, for RNA biosensing. However, there is currently no systematic guide on selecting the most appropriate RNA-targeting CRISPR-Cas system for a ...
Escarlet Díaz-Galicia   +2 more
doaj   +1 more source

The engineered single guide RNA structure as a biomarker for gene-editing reagent exposure

open access: yesScientific Reports, 2023
CRISPR arrays and CRISPR-associated (Cas) proteins comprise a prevalent adaptive immune system in bacteria and archaea. These systems defend against exogenous parasitic mobile genetic elements.
Emmarie C. Ryan   +2 more
doaj   +1 more source

Carrier strategies boost the application of CRISPR/Cas system in gene therapy

open access: yesExploration, 2022
Emerging clustered regularly interspaced short palindromic repeat/associated protein (CRISPR/Cas) genome editing technology shows great potential in gene therapy.
Zunkai Xu   +10 more
doaj   +1 more source

Guide RNAs: A Glimpse at the Sequences that Drive CRISPR–Cas Systems [PDF]

open access: yesCold Spring Harbor Protocols, 2016
CRISPR–Cas systems provide adaptive immunity in bacteria and archaea. Although there are two main classes of CRISPR–Cas systems defined by gene content, interfering RNA biogenesis, and effector proteins, Type II systems have recently been exploited on a broad scale to develop next-generation genetic engineering and genome-editing tools.
Alexandra E, Briner, Rodolphe, Barrangou
openaire   +2 more sources

CRISPR based therapeutics: a new paradigm in cancer precision medicine

open access: yesMolecular Cancer, 2022
Background Clustered regularly interspaced short palindromic repeat (CRISPR)-CRISPR-associated protein (Cas) systems are the latest addition to the plethora of gene-editing tools.
Sumit Das   +3 more
doaj   +1 more source

Functional Identification of the Xanthomonas oryzae pv. oryzae Type I-C CRISPR-Cas System and Its Potential in Gene Editing Application

open access: yesFrontiers in Microbiology, 2021
The type I clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) system is one of five adaptive immune systems and exists widely in bacteria and archaea. In this study, we showed that Xanthomonas oryzae pv.
Qibing Liu   +6 more
doaj   +1 more source

RNA-guided editing of bacterial genomes using CRISPR-Cas systems [PDF]

open access: yesNature Biotechnology, 2013
Here we use the clustered, regularly interspaced, short palindromic repeats (CRISPR)-associated Cas9 endonuclease complexed with dual-RNAs to introduce precise mutations in the genomes of Streptococcus pneumoniae and Escherichia coli. The approach relies on dual-RNA:Cas9-directed cleavage at the targeted genomic site to kill unmutated cells and ...
Jiang, Wenyan   +4 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy